Brian McNamee
Chairman chez CSL LIMITED
Fortune : 24 M $ au 31/03/2024
Profil
Brian Anthony McNamee is currently the Chairman at CSL Ltd., Chairman & Independent Non-executive Director at CSL Behring LLC, Chairman at Geoff Ogilvy Foundation, and Director at CSL Innovation Pty Ltd.
He previously served as the Chief Executive Officer, Executive Director & MD at CSL Ltd.
from 1990 to 2013.
Additionally, he was the Chairman at Genesis Care Pty Ltd.
from 2019 to 2022 and a Director at Gen-Probe, Inc. from 2010 to 2011.
He also held the position of Managing Director at Pacific Biotechnology Ltd.
and Director at Peter Maccallum Cancer Foundation Ltd.
Furthermore, he served as the General Manager-Faulding Product Divisions at FH Faulding & Co. Ltd.
and President at CSL Behring LLC.
He started his career as the Principal at Tarnagulla Ventures Pty Ltd.
Dr. McNamee obtained an undergraduate degree and a doctorate from the University of Melbourne in 1979.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CSL LIMITED
0,03% | 16/02/2024 | 126 227 ( 0,03% ) | 24 M $ | 31/03/2024 |
Postes actifs de Brian McNamee
| Sociétés | Poste | Début |
|---|---|---|
| ZENYTH THERAPEUTICS LIMITED | Director/Board Member | - |
| CSL LIMITED | Chairman | 17/10/2018 |
| Geoff Ogilvy Foundation | Chairman | 01/05/2021 |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Chairman | - |
Anciens postes connus de Brian McNamee
| Sociétés | Poste | Fin |
|---|---|---|
Genesis Care Pty Ltd.
 Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Chairman | 01/06/2022 |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | President | 01/07/2013 |
| CSL LIMITED | President | 01/07/2013 |
Gen-Probe, Inc.
 Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Director/Board Member | 31/05/2007 |
Tarnagulla Ventures Pty Ltd.
 Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Private Equity Investor | - |
Formation de Brian McNamee
| University of Melbourne | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CSL LIMITED | Health Technology |
| Entreprise privées | 9 |
|---|---|
CSL Innovation Pty Ltd.
 CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia. | Health Technology |
Gen-Probe, Inc.
Gen-Probe, Inc. Medical SpecialtiesHealth Technology Gen-Probe, Inc. develops, manufactures and markets rapid, accurate and molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. It also develops and manufactures the PROCLEIX assays, which are used to detect human immunodeficiency virus, the hepatitis C virus, the hepatitis B virus, and the West Nile virus in donated human blood. The firm's clinical diagnostics products include APTIMA family of assays, which are used to detect the common STDs chlamydia and gonorrhea. Gen-Probe was founded by Thomas H. Adams and David E. Kohne in 1983 and is headquartered in San Diego, CA. | Health Technology |
| FH Faulding & Co. Ltd. | Health Technology |
CSL Behring LLC
CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Health Technology |
| Pacific Biotechnology Ltd. | |
Genesis Care Pty Ltd.
Genesis Care Pty Ltd. Hospital/Nursing ManagementHealth Services Genesis Care Pty Ltd. engages in the provision of radiation oncology cardiology and sleep treatments. It offers oncology, cardiology, sleep medicine, and theranostics. The company was founded by Dan Collins in 2009 and is headquartered in Alexandria, Australia. | Health Services |
| Peter Maccallum Cancer Foundation Ltd. | |
Tarnagulla Ventures Pty Ltd.
Tarnagulla Ventures Pty Ltd. Investment ManagersFinance Tarnagulla Ventures Pty Ltd (Tarnagulla Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Melbourne, Australia. | Finance |
| Geoff Ogilvy Foundation |
